American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about First Industrial Realty Trust, Inc. (NYSE:FR) Receives Consensus Recommendation of “Hold” from Brokerages

First Industrial Realty Trust, Inc. (NYSE:FR) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of First Industrial Realty Trust, Inc. (NYSE:FR – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten research firms that are presently covering the stock, MarketBeat Ratings... More of this article »
Image about Chegg, Inc. (NYSE:CHGG) Receives Consensus Recommendation of “Reduce” from Analysts

Chegg, Inc. (NYSE:CHGG) Receives Consensus Recommendation of “Reduce” from Analysts

Shares of Chegg, Inc. (NYSE:CHGG – Get Free Report) have received an average rating of “Reduce” from the ten brokerages that are currently covering the stock, Marketbeat.com reports. Four analysts have rated the... More of this article »
Image about StoneCo Ltd. (NASDAQ:STNE) Receives Average Recommendation of “Moderate Buy” from Brokerages

StoneCo Ltd. (NASDAQ:STNE) Receives Average Recommendation of “Moderate Buy” from Brokerages

StoneCo Ltd. (NASDAQ:STNE – Get Free Report) has earned an average rating of “Moderate Buy” from the nine brokerages that are covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold... More of this article »
Image about PBF Energy Inc. (NYSE:PBF) Given Consensus Rating of “Hold” by Brokerages

PBF Energy Inc. (NYSE:PBF) Given Consensus Rating of “Hold” by Brokerages

Shares of PBF Energy Inc. (NYSE:PBF – Get Free Report) have been given a consensus rating of “Hold” by the eleven research firms that are covering the stock, Marketbeat reports. Six research analysts have rated the... More of this article »
Image about Bath & Body Works, Inc. (NYSE:BBWI) Receives Consensus Rating of “Hold” from Brokerages

Bath & Body Works, Inc. (NYSE:BBWI) Receives Consensus Rating of “Hold” from Brokerages

Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have been given an average recommendation of “Hold” by the fourteen ratings firms that are currently covering the company, MarketBeat Ratings reports.... More of this article »
Image about Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) has earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat.com reports. One analyst... More of this article »
Image about GXO Logistics, Inc. (NYSE:GXO) Receives Average Recommendation of “Buy” from Analysts

GXO Logistics, Inc. (NYSE:GXO) Receives Average Recommendation of “Buy” from Analysts

GXO Logistics, Inc. (NYSE:GXO – Get Free Report) has been assigned an average recommendation of “Buy” from the ten ratings firms that are currently covering the company, Marketbeat.com reports. Ten equities research... More of this article »
Image about Air Products and Chemicals, Inc. (NYSE:APD) Receives Consensus Recommendation of “Hold” from Brokerages

Air Products and Chemicals, Inc. (NYSE:APD) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Air Products and Chemicals, Inc. (NYSE:APD – Get Free Report) have received an average rating of “Hold” from the fifteen brokerages that are presently covering the stock, Marketbeat Ratings reports. One... More of this article »
Image about Adobe (NASDAQ:ADBE) Given New $630.00 Price Target at Royal Bank of Canada

Adobe (NASDAQ:ADBE) Given New $630.00 Price Target at Royal Bank of Canada

Adobe (NASDAQ:ADBE – Free Report) had its price target lowered by Royal Bank of Canada from $650.00 to $630.00 in a report released on Friday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the software... More of this article »
Image about TD Cowen Trims Adobe (NASDAQ:ADBE) Target Price to $640.00

TD Cowen Trims Adobe (NASDAQ:ADBE) Target Price to $640.00

Adobe (NASDAQ:ADBE – Free Report) had its price objective decreased by TD Cowen from $650.00 to $640.00 in a report released on Friday, Benzinga reports. TD Cowen currently has an outperform rating on the software company’s... More of this article »
Image about Adobe (NASDAQ:ADBE) PT Lowered to $640.00

Adobe (NASDAQ:ADBE) PT Lowered to $640.00

Adobe (NASDAQ:ADBE – Free Report) had its target price cut by Bank of America from $700.00 to $640.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a buy rating on the software... More of this article »
Image about Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $260.00 at Wells Fargo & Company

Ascendis Pharma A/S (NASDAQ:ASND) PT Raised to $260.00 at Wells Fargo & Company

Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its target price increased by Wells Fargo & Company from $196.00 to $260.00 in a research report sent to investors on Friday, Benzinga reports. They currently have an overweight... More of this article »
Image about Lucid Diagnostics (LUCD) Set to Announce Earnings on Tuesday

Lucid Diagnostics (LUCD) Set to Announce Earnings on Tuesday

Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) will post its quarterly earnings results before the market opens on Tuesday, March 26th. Individual interested in registering for the company’s earnings conference call... More of this article »
Image about Wayfair Inc. (NYSE:W) Receives Average Recommendation of “Moderate Buy” from Analysts

Wayfair Inc. (NYSE:W) Receives Average Recommendation of “Moderate Buy” from Analysts

Wayfair Inc. (NYSE:W – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated... More of this article »
Image about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-five ratings firms that are presently covering the company, Marketbeat Ratings... More of this article »